Natera, Inc.
Unlock to Claim this listing
Add / Modify Company
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual’s tumor; and Prospera used to assess organ transplant rejection.
3.3
Overall Excellence Rating
Industry
HealthcareCategory
Diagnostics & ResearchESG/Ethical Impact
Reduce non-biohazardous waste footprint per test kit by 25%. Achieve 80% non-biohazardous waste diversion for our Austin and San Carlos sites.Transition 50% of sales fleet to electric vehicles. Achieve My Green Lab Certification at Austin and San Carlos sitesAchieve 100% of people managers to complete annual Diversity, Equity, and Inclusion (DEI) training. Perform annual pay equity analysis and adjust as appropriateIncrease diversity of executive leadership. Provide updates on ESG initiatives to Board twice annuallyNatera’s financial sustainability is closely intertwined with its dedication to innovation. The company’s investment in research and development drives advancements in genetic testing and diagnostics, contributing to improved patient care. By embracing strategic financial management and fostering innovation, Natera ensures long-term value creation while pushing the boundaries of healthcare technology.Natera’s ethical responsibility extends to its genetic testing and data management practices. The company places patient data privacy and security at the forefront, ensuring that its testing solutions adhere to stringent data protection protocols. By maintaining robust ethical data practices, Natera contributes to secure and responsible genetic testing and data management.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
$820,000,000.00
Website Traffic
Employee Rating
3.3
Customer Rating
2.8
Company Size
1000-5000
ESG Risk Rating
2